Thompson Davis & Co., Inc. Abb Vie Inc. Transaction History

Thompson Davis & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $315,287 - $400,833	2,291 New	2,291 $351,000
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $686,296 - $851,500	-5,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $558,636 - $706,836	5,200 New	5,200 $704,000
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $22,445 - $26,557	-250 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$92.01 - $123.21 $23,002 - $30,802	250 New	250 $24,000
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $5,104 - $5,597	-57 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	57	57 $4,000

4,095

1.28B

16.7M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.